novartis

  1. At last, Novartis gets rid of Alcon

    Novartis is demerging its troubled eyecare unit Alcon, most probably next year. I'm sure the spin-off would reduce Alcon's value considerably. If it was taken public, instead of the spin-off, it would have have been a much better deal, I think. It seems the new CEO has bigger plans for Novartis.
  2. Novartis-AveXis : A ‘gene’-ius deal?

    Novartis is wagering high on gene therapy with its proposed acquisit ion of AveXis Inc. valued at $8.7 billion. The high-premium deal is expected to be completed in mid-2018. Source https://news.alphastreet.com/novartis-avexis-a-gene-ius-deal/ "The pharmaceutical sector is witnessing many...
  3. Novartis-Gate: 2 Prime Ministers, 8 Ministers involved in Greece’s Kickback Scandal

    The names of two prime ministers and eight ministers of Health, Finance and Development are involved in the Novartis bribe scandal, media report Monday afternoon, after the prosecutor decided to forward the investigation findings to the Greek Parliament. The scandal is estimated to be worth 85...
  4. Sandoz wins the patent case against Allergan

    This is the second patent win for Sandoz in December 2017. Allergan is expected to file for rehearing within 30 days on patent ruling. Earlier in Dec., Sandoz also won a patent case against Amgen.
  5. Lilly in the migraine drug race

    http://alph.st/bf3c0558 Lilly joins the migraine drug race with Novartis and Amgen, as FDA accepts to review Lilly's Galcanezumab. Already, Teva filed a lawsuit in October 2017, seeking to block Lilly's migraine drug to market in the U.S. The size of the migraine market is expected to more than...
  6. Novartis' sells plant in New York for $18M, then new owners flip property for $30M!

    What a shame.... over 500 US workers loose their jobs (since 2014) and the company also looses $12 million in the sale of the property. Novartis has sold its plant in Suffern, N.Y., which was then quickly resold. The vacant Novartis manufacturing facility in...
  7. Vas CEO: let's bet what line function is offshored next ?

    In May we had data management and programming. Despite the fact that it looks already like a failure, it won't stop them, what line function is going next to Hyderabad ? I am betting: 2018: Stats 2019: GCM (trial management) 2020: surprise !! What you think ?
  8. Open Letter to MB, DE and RN

    Guys, now you have decided that Asia exists in the planet and made a decision to move the alleged NVS Korea Scam hero EVO out of Asia and brought RN to lead, and removed Vietnam scam hero RL to Europe to destroy Russia & EE, please note the below also for quick actions 1. alleged NVS Korea...
  9. Badhri Srinivasan

    A fish rots from the head down... You are not only an idiot, but also the worst kind of leader a company can expect: arrogant, ignorant and stubborn. Your crap decisions will have huge consequences not only for the associates who will lose their job, but also for the company. You can make as...
  10. Novartis Oncology - Why are so many great people leaving?

    Why are so many great people leaving Novartis Oncology? This ones was a special place. Now many great managers and talents have left (Global, Development, US, EGM). Thereby you can almost watch a negative selection. How can this be?